Alamar Biosciences, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Alamar Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $1.21M, a 639.63% increase year-over-year.
- Alamar Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $661.00K, a 172.02% increase year-over-year.
- Alamar Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $164.00K.
- Alamar Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $243.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $1.21M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $661.00K 10-Q · filed 2026-08-11 | |
| 2025-06-30 | $164.00K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $243.00K 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |